Literature DB >> 25028883

Investigating the structural impact of the glutamine repeat in huntingtin assembly.

Tatiana Perevozchikova1, Christopher B Stanley2, Helen P McWilliams-Koeppen1, Erica L Rowe1, Valerie Berthelier3.   

Abstract

Acquiring detailed structural information about the various aggregation states of the huntingtin-exon1 protein (Htt-exon1) is crucial not only for identifying the true nature of the neurotoxic species responsible for Huntington's disease (HD) but also for designing effective therapeutics. Using time-resolved small-angle neutron scattering (TR-SANS), we followed the conformational changes that occurred during fibrillization of the pathologic form of Htt-exon1 (NtQ42P10) and compared the results with those obtained for the wild-type (NtQ22P10). Our results show that the aggregation pathway of NtQ22P10 is very different from that of NtQ42P10, as the initial steps require a monomer to 7-mer transition stage. In contrast, the earliest species identified for NtQ42P10 are monomer and dimer. The divergent pathways ultimately result in NtQ22P10 fibrils that possess a packing arrangement consistent with the common amyloid sterical zipper model, whereas NtQ42P10 fibrils present a better fit to the Perutz β-helix structural model. The structural details obtained by TR-SANS should help to delineate the key mechanisms that underpin Htt-exon1 aggregation leading to HD.
Copyright © 2014 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25028883      PMCID: PMC4104047          DOI: 10.1016/j.bpj.2014.06.002

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  41 in total

1.  Quantification of beta-sheet amyloid fibril structures with thioflavin T.

Authors:  H LeVine
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

2.  The polymerization of actin: structural changes from small-angle neutron scattering.

Authors:  Alexander I Norman; Robert Ivkov; Jeffrey G Forbes; Sandra C Greer
Journal:  J Chem Phys       Date:  2005-10-15       Impact factor: 3.488

3.  Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation.

Authors:  Eric J Bennett; Neil F Bence; Rajadas Jayakumar; Ron R Kopito
Journal:  Mol Cell       Date:  2005-02-04       Impact factor: 17.970

4.  Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology.

Authors:  E Scherzinger; A Sittler; K Schweiger; V Heiser; R Lurz; R Hasenbank; G P Bates; H Lehrach; E E Wanker
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

5.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Authors: 
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

6.  All-atom stability and oligomerization simulations of polyglutamine nanotubes with and without the 17-amino-acid N-terminal fragment of the Huntingtin protein.

Authors:  Sébastien Côté; Guanghong Wei; Normand Mousseau
Journal:  J Phys Chem B       Date:  2012-09-28       Impact factor: 2.991

7.  Huntingtin is cleaved by caspases in the cytoplasm and translocated to the nucleus via perinuclear sites in Huntington's disease patient lymphoblasts.

Authors:  Akira Sawa; Eiichiro Nagata; Siobhan Sutcliffe; Pratima Dulloor; Matthew B Cascio; Yuji Ozeki; Sophie Roy; Christopher A Ross; Solomon H Snyder
Journal:  Neurobiol Dis       Date:  2005-11       Impact factor: 5.996

8.  Huntingtin spheroids and protofibrils as precursors in polyglutamine fibrilization.

Authors:  Michelle A Poirier; Huilin Li; Jed Macosko; Shuowei Cai; Mario Amzel; Christopher A Ross
Journal:  J Biol Chem       Date:  2002-08-08       Impact factor: 5.157

9.  Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

Authors:  F Saudou; S Finkbeiner; D Devys; M E Greenberg
Journal:  Cell       Date:  1998-10-02       Impact factor: 41.582

10.  Hsp70 and Hsp40 attenuate formation of spherical and annular polyglutamine oligomers by partitioning monomer.

Authors:  Jennifer L Wacker; M Hadi Zareie; Hanson Fong; Mehmet Sarikaya; Paul J Muchowski
Journal:  Nat Struct Mol Biol       Date:  2004-11-14       Impact factor: 15.369

View more
  7 in total

1.  Protofilament Structure and Supramolecular Polymorphism of Aggregated Mutant Huntingtin Exon 1.

Authors:  Jennifer C Boatz; Talia Piretra; Alessia Lasorsa; Irina Matlahov; James F Conway; Patrick C A van der Wel
Journal:  J Mol Biol       Date:  2020-06-27       Impact factor: 5.469

Review 2.  Emerging applications of small angle solution scattering in structural biology.

Authors:  Barnali N Chaudhuri
Journal:  Protein Sci       Date:  2015-02-12       Impact factor: 6.725

3.  The 17-residue-long N terminus in huntingtin controls stepwise aggregation in solution and on membranes via different mechanisms.

Authors:  Nitin K Pandey; J Mario Isas; Anoop Rawat; Rachel V Lee; Jennifer Langen; Priyatama Pandey; Ralf Langen
Journal:  J Biol Chem       Date:  2017-12-27       Impact factor: 5.157

4.  Fibril polymorphism affects immobilized non-amyloid flanking domains of huntingtin exon1 rather than its polyglutamine core.

Authors:  Hsiang-Kai Lin; Jennifer C Boatz; Inge E Krabbendam; Ravindra Kodali; Zhipeng Hou; Ronald Wetzel; Amalia M Dolga; Michelle A Poirier; Patrick C A van der Wel
Journal:  Nat Commun       Date:  2017-05-24       Impact factor: 14.919

5.  Conformational studies of pathogenic expanded polyglutamine protein deposits from Huntington's disease.

Authors:  Irina Matlahov; Patrick Ca van der Wel
Journal:  Exp Biol Med (Maywood)       Date:  2019-06-15

6.  Polyglutamine amyloid core boundaries and flanking domain dynamics in huntingtin fragment fibrils determined by solid-state nuclear magnetic resonance.

Authors:  Cody L Hoop; Hsiang-Kai Lin; Karunakar Kar; Zhipeng Hou; Michelle A Poirier; Ronald Wetzel; Patrick C A van der Wel
Journal:  Biochemistry       Date:  2014-10-16       Impact factor: 3.162

Review 7.  Implications of the Orb2 Amyloid Structure in Huntington's Disease.

Authors:  Rubén Hervás; Alexey G Murzin; Kausik Si
Journal:  Int J Mol Sci       Date:  2020-09-21       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.